ArticleWorld journal of gastrointestinal surgery2026
Safety and efficacy of endoscopic papillectomy for duodenal papillary adenomas: A single-center retrospective study.
Article in World journal of gastrointestinal surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPancreaticoduodenectomy (PD) is currently the preferred surgical procedure to remove duodenal papillary adenoma. It offers a low recurrence rate, but a high rate of postoperative complications.
aimTo determine the efficacy and safety of endoscopic papillectomy (EP) for duodenal papillary adenoma.
methodsThis retrospective case-control study included 102 patients who received treatment at Nanjing Drum Tower Hospital between January 2010 and December 2024. Clinicopathological features, adverse events, and outcomes were compared between the two groups.
resultsAfter propensity score matching for sex, year, and tumor size, 37 patients each were assigned to the PD and EP groups. All patients underwent successful removal of the diseased tissues. The pathological analysis revealed no significant differences between the two groups (
conclusionEP may be effective and safe for the removal of duodenal papillary adenoma in a minimally invasive manner, and can offer superior long-term survival compared with conventional PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.